Insider Transactions in Q4 2020 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2020
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
6,500
-1.32%
|
$312,000
$48.82 P/Share
|
|
Dec 28
2020
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+2.56%
|
$0
$0.85 P/Share
|
|
Dec 24
2020
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,376
-2.48%
|
$168,800
$50.0 P/Share
|
|
Dec 23
2020
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
4,500
-1.83%
|
$225,000
$50.0 P/Share
|
|
Dec 23
2020
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.8%
|
$0
$0.85 P/Share
|
|
Dec 23
2020
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
21,124
-13.41%
|
$1,056,200
$50.01 P/Share
|
|
Dec 16
2020
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
15,000
-5.86%
|
$675,000
$45.0 P/Share
|
|
Dec 16
2020
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+5.54%
|
$0
$0.85 P/Share
|
|
Dec 11
2020
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,916
-8.65%
|
$596,640
$40.17 P/Share
|
|
Dec 10
2020
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
4,500
-1.83%
|
$180,000
$40.0 P/Share
|
|
Dec 10
2020
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.8%
|
$0
$0.85 P/Share
|
|
Dec 10
2020
|
Vittal Vasista Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,584
-11.58%
|
$903,360
$40.06 P/Share
|